This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Bioswan Laboratories, Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Guowei Wei: Innovator in Monoclonal Antibody Research
Introduction
Guowei Wei is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work is crucial for advancements in medical diagnostics and therapies.
Latest Patents
Guowei Wei holds a patent titled "Monoclonal Antibody for Detection of CAR-T Cells, Kit and Application." This innovative patent addresses the detection of CAR-T cells, which are vital in cancer immunotherapy. His research has the potential to enhance the effectiveness of cancer treatments.
Career Highlights
Wei is associated with Suzhou Bioswan Laboratories, Co., Ltd., where he continues to push the boundaries of scientific research. His dedication to innovation has led to the development of cutting-edge technologies in the field of immunology.
Collaborations
Guowei Wei collaborates with talented individuals such as Liang Da and Xin Chen. Their combined expertise fosters a productive research environment that drives forward the company's objectives.
Conclusion
Guowei Wei's contributions to monoclonal antibody research exemplify the impact of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile